What's New

Medical News
& Alerts

Conferences
& Meetings


Other Medical
Resources

Employment
Opportunities

Partnering
Opportunities

Search results for: Adriamycin
95%DGNews: Early Results Show Taxol/Adriamycin Effective In Breast Cancer
94%DGNews: Taxotere/Cyclophosphamide Offers Greater Disease-Free Survival for Early-Stage Breast Cancer Patients: Presented at SABCS
94%DGNews: DG DISPATCH - USCAP: Taxanes Promote Necrosis In Advanced Breast Cancer
93%DGNews: AACR: Suramin/Adriamycin Appears Active In Hormone Refractory Prostate Cancer
93%DGNews: ASCO MEETING: Taxotere Plus Adriamycin Outperforms Standard Combination In Breast Cancer
92%DGNews: SABCS: Risk of Congestive Heart Failure Low with Taxol (Paclitaxel)-Herceptin (Trastuzumab) Adjuvant Therapy
92%DGNews: FDA Approves Herceptin For Breast Cancer
91%DGNews: Protein Found to Protect Breast Cancer Tumors From Chemotherapy
91%DGNews: SABCS: Amended Protocol Improves Quality Assurance for HER2 IHC Testing
91%DGNews: BREAST CANCER SYMPOSIUM: Taxotere With Adriamycin, Cytoxan Effective For Metastatic Breast Cancer
90%DGNews: Doxorubicin/Cyclophosphamide as Effective as Doxorubicin/Docetaxel (AT) for Early-Stage Breast Cancer
90%DGNews: SABCS: Dose-intense Chemotherapy Regimen Reduces Toxicity
90%DGNews: DG DISPATCH - ATPBC: Dose-Dense Preoperative Chemotherapy Combination Is Favorable For Patients With Operable Breast Cancer
89%DGNews: SABCS: Substitution of Docetaxel for 5-Fluorouracil in Standard Early Breast Cancer Chemotherapy Reduces Risk of Death and Cancer Recurrence
89%DGNews: Breast Cancer Research: Canada to Lead $15 Million International Program
88%DGNews: ICML: Dose-Escalated CHOP Therapy plus Etoposide Effective against Aggressive Non-Hodgkin's Lymphoma
88%DGNews: ASCO: Dexamethasone, Thalidomide plus PACE Effective in Multiple Myeloma
88%DGNews: Taxotere First Drug To Outperform Adriamycin in Metastatic Breast Cancer
88%DGNews: ImClone Systems Initiates Phase Ib/IIa Prostate Cancer Clinical Trials
88%DGNews: ASCO-DG DISPATCH: Breast Cancer Meeting Highlights
87%DGNews: ICML: ChlVPP/EVA hybrid chemotherapy effective against Hodgkin's disease
87%DGNews: Worldwide Research Group To Compare Breast Cancer Treatments
86%DGNews: DNA Amplification and Elevated CKS1B Expression Associated With Poor Survival in Multiple Myeloma: Presented at ICML
86%DGNews: ASTRO: ABVD Effective for Hodgkin's, but Pulmonary Toxicity May be Worse for Elderly
86%DGNews: SABCS: No Connection Between Anemia and Outcome in Patients Undergoing Breast Cancer Chemotherapy
86%DGNews: Taxotere Combination Effective First-Line Treatment of Metastatic Breast Cancer
86%DGNews: DaunoXome Approved by FDA As First-line Therapy For Kaposi's Sarcoma
86%DGNews: Taxotere The First Breast Cancer Drug to Outperform Adriamycin
85%DGNews: Hepatocellular Carcinoma Treatment Options Remain Limited, but New Avenues Are Being Explored: Presented at HEP DART
85%DGNews: Addition of Rituximab to Combination Chemotherapy Improves Outcomes in Advanced Stage Lymphoplasmocytoid/ic Immunocytoma: Presented at ICML
85%DGNews: ASH: Hodgkin's Patients Benefit from Less Intense Therapy
85%DGNews: ASH: Physicians May Need to Dig Deeper when Treating HIV-Related Lymphomas
85%DGNews: NHL 2004: Addition of Rituximab to Standard Chemotherapy Regimen Improves Survival in Aggressive Non-Hodgkin's Lymphoma
85%DGNews: ICACT: Docetaxel-Doxorubicin Dose-Dense Sequential Treatment Prolongs Survival in Stage II and III Breast Cancer
85%DGNews: ASH: Addition of Rituximab to Combination Chemotherapy Significantly Improves Treatment of Mantle Cell Lymphomas
85%DGNews: SMFM: Chemotherapy May Be Safe for Many Pregnant Women with Cancer
85%DGNews: SABCS: Eight-Week Chemotherapy Schedule as Well Tolerated as Twenty-Four Week
85%DGNews: DG DISPATCH - SGO: Resistance To Cisplatin And Other Second Agents Verified With Assay
84%DGNews: Less Aggressive Regimen as Effective and Equally Tolerated as Standard Treatment for Elderly Patients With Aggressive Non-Hodgkin's Lymphoma: Presented at ICML
84%DGNews: ICACT: Amsacrine/Cisplatin Combination Offers Low-Toxicity Option for Metastatic Urothelial Cancer
84%DGNews: ASCO: Weekly Paclitaxel Better Than Standard Dosage For Breast Cancer Treatment
84%DGNews: Breast Cancer Susceptibility Gene Linked To Poor Chemotherapy Response
84%DGNews: DG DISPATCH - ASCO: Herceptin (Trastuzumab) Prompts Promising Response In Advanced Breast Cancer
84%DGNews: ICACT: Taxotere And Adriamycin Combo Effective For Breast Cancer
84%DGNews: NSABP To Begin New Trial of Taxotere(r) (docetaxel) For Breast Cancer
83%DGNews: Benefits of Herceptin Are Lasting, Reducing HER2 + Breast Cancer Deaths and Recurrence: Presented at ASCO
83%DGNews: Zevalin Used in Abbreviated Chemotherapy Regimen Shows Efficacy for Follicular Non-Hodgkin's Lymphoma: Presented at ASH
83%DGNews: Taxane-Based Breast Cancer Treatment Cost-Effective Compared With 5-Fluorouracil-Based Therapy: Presented at SABCS
83%DGNews: HFSA: Carvedilol Alone or in Combination With Standard Therapy Reverses Chemotherapy-Induced Congestive Heart Failure
83%DGNews: IBCC: Microwave Therapy Improves Chance Of Saving Breast
Enter keywords you wish to find information about:

Search for documents that contain:
any of these words.
this exact phrase.
all of these words.

 

 

This site is maintained by webmaster@pslgroup.com
Please contact us with any comments, problems or bugs.

All contents Copyright (c) 1998 PSL Consulting Group Inc.
all rights reserved.